U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07356050) titled 'Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease' on Jan. 07.
Brief Summary: The goal of this study is to learn if infants with sickle cell disease (SCD) develop adequate protection after measles vaccines. (not looking at any prolonged duration)
Study Start Date: March 13, 2025
Study Type: OBSERVATIONAL
Condition:
Sickle Cell Disease
Measles Vaccination
Sickle Cell Anemia
Recruitment Status: RECRUITING
Sponsor: Children's Hospital Medical Center, Cincinnati
Disclaimer: Curated by HT Syndication....